HSA-2023-0052-V252
Type II variation for application HSA-2023-0052. Type II variation: Facility Change for Respiralimab — critical change
Variation Number
HSA-2023-0052-V252
Type
Type II
Application
Change
Status
Completed
Fee
€9,824
Submitted
—
Approved
—
Description
Type II variation: Facility Change for Respiralimab — critical change